Skip to main content

Table 1 Clinical characteristics of RRMS and control subjects

From: Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease

Characteristics RRMS group (n = 50) Control group (n = 50)
Age 35.08 (19–65) 33.01 (22–51)
Gender (female/male) 36/14 31/19
EDSS 1.75 ± 0.31 NA
Disease duration 4.9 ± 1.6 (2–15 years) NA
  1. Data are shown as mean ± SD or frequencies
  2. NA non-applicable, EDSS expanded disability status scale